Envestnet Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,925
| Closed | -$644K | – | 4114 |
|
|
2021
Q4 | $644K | Sell |
6,925
-8
| -0.1% | -$527 | ﹤0.01% | 2914 |
|
|
2021
Q3 | $413K | Buy |
6,933
+1,514
| +28% | +$89.4K | ﹤0.01% | 3094 |
|
|
2021
Q2 | $370K | Buy |
5,419
+665
| +14% | +$43.4K | ﹤0.01% | 3157 |
|
|
2021
Q1 | $330K | Buy |
4,754
+2
| +0% | +$154 | ﹤0.01% | 3086 |
|
|
2020
Q4 | $365K | Sell |
4,752
-1,137
| -19% | -$85.2K | ﹤0.01% | 2824 |
|
|
2020
Q3 | $440K | Buy |
5,889
+1,221
| +26% | +$81.4K | ﹤0.01% | 2533 |
|
|
2020
Q2 | $294K | Sell |
4,668
-6,939
| -60% | -$382K | ﹤0.01% | 2691 |
|
|
2020
Q1 | $487K | Buy |
11,607
+6,865
| +145% | +$315K | ﹤0.01% | 2261 |
|
|
2019
Q4 | $215K | Sell |
4,742
-421
| -8% | -$19.9K | ﹤0.01% | 2895 |
|
|
2019
Q3 | $236K | Buy |
+5,163
| New | +$290K | ﹤0.01% | 2788 |
|
|
2015
Q1 | – | Sell |
-115
| Closed | -$4K | – | 2500 |
|
|
2014
Q4 | $4K | Buy |
+115
| New | +$4.67K | ﹤0.01% | 2213 |
|
|
2014
Q2 | – | Sell |
-50
| Closed | -$3K | – | 2838 |
|
|
2014
Q1 | $3K | Buy |
+50
| New | +$3.32K | ﹤0.01% | 2239 |
|
Envestnet Asset Management's ARNA Position: Q1 2022 in Review
Envestnet Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 6,925 shares — an estimated $644K sold.
Envestnet Asset Management first reported a position in ARNA in Q1 2014 and held it in 12 quarters. The position peaked at $644K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Envestnet Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Envestnet Asset Management sold 6,925 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $644K.
- Envestnet Asset Management first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 12 quarters.
- Envestnet Asset Management's Arena Pharmaceuticals Inc position peaked at $644K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Envestnet Asset Management's 13F filing for Q1 2022, filed 4 May 2022.